Journal: Nature Communications
Article Title: Gut microbiota-derived GlcNAc-MurNAc is a TLR4 agonist that protects the host gut
doi: 10.1038/s41467-025-60678-5
Figure Lengend Snippet: a Timeline of the study, where GM was intraperitoneally administered at 10 mg/kg to mice (WT and Tlr4 -/- ) that were provided with 3% DSS or normal drinking water. I.p. injections of PBS were given to the negative control group. b-c Measurements of mice body weight ( b ) ( n = 8, 6, 10, 10, 9, 8, 10, 10, respectively) and colon length ( c ) ( n = 8, 6, 14, 14, 8, 8, 15, 14, respectively) at the endpoint of the timeline. d-e Representative images of colons ( d ) and H&E-stained colon sections ( e ) from each group ( n = 5). f Flow cytometry analysis of immune cell infiltration in the colons of each treatment group. The percentage of the CD45 + population ( n = 8, 6, 12, 13, 7, 8, 12, 12, respectively) was calculated within pre-gated live cells. The percentage of Ly6C + MHCII - ( n = 8, 6, 10, 10, 7, 8, 10, 8, respectively) and Ly6C + Ly6G + ( n = 8, 6, 8, 8, 7, 8, 11, 9, respectively) populations was calculated within the CD45 + population. g RT-qPCR analysis of colonic cytokines demonstrates the significantly reduced inflammation in the GM-supplemented DSS-induced colitis in WT mice but not Tlr4 -/- mice. Tnfα , n = 10, 10, 9, 9, 5, 8, 8, 8, respectively. Il1β , n = 12, 12, 10, 13, 5, 8, 8, 7, respectively. Ccl2 , n = 10, 10, 9, 9, 5, 8, 6, 6, respectively. Data are presented as mean values ± s.e.m. ( n as indicated) with indicated P values determined using two-way ANOVA followed by Tukey’s multiple comparison for ( c, f-g ). All experiments were repeated twice with similar results. Source data are provided as a file.
Article Snippet: Recombinant mouse TLR4 (26-638)-His 6 protein (Cusabio, Cat. No. CSB-YP023603MO) was reconstituted in water and aliquoted for storage at −80 °C.
Techniques: Negative Control, Staining, Flow Cytometry, Quantitative RT-PCR, Comparison